Interestingly, IL-5 levels were consistently elevated in BT patients with allergic asthma (AA), suggesting persistent eosinophilic inflammation despite biological therapy, more likely unaffected by TNF-α or IL-17 blockade. The gene discussed is IL17A; the disease is allergic asthma.